About Us
At Citi Pharma, we are driven by a mission to enhance global health by providing world-class pharamaceutical products with precision and care.
WELCOME TO
Citi Pharma
The factory is located at 3km Head Balloki road, Kasur. It has a land of 47 acres and has more than 800,000 Sq. Feet covered area. Citi Pharma got its first project in 1990 by AWT. Then the major plant erection period started in 1993 and ended somewhere in 1996. Production commenced in 1996 and formulation established in 2003.
Citi Pharma mission is to dedicate itself top adding exceptional value through creation of innovative and cost effective Pharma products and develop a corporate culture that rewards initiative, enthusiasm and ethical practices.
MISSION & VISION
Supporting this vision, Citi Pharma is actively developing a state-of-the-art Bioequivalence Center, set to be operational by 2026, to conduct clinical trials, ensure regulatory compliance, and accelerate drug approvals. Combined with our 25,000 sq. ft. R&D facility—Pakistan’s largest—our efforts in bioequivalence research and biotech development will help shape a future where healthcare is safer, smarter, and more personalized.
Citi Pharma’s mission is to dedicate itself exceptional value through creation of innovative & cost-effective pharma products and develop a corporate culture that rewards initiative, enthusiasm and ethical practices.
We aim to be among the top pharmaceutical companies in Pakistan by constantly evolving and bringing home innovative products in healthcare segment.
CEO MESSAGE
At Citi Pharma, our purpose – Care to Cure – goes beyond business. It reflects our unwavering commitment to transforming lives through science, innovation, and compassion. We are proud to be at the forefront of Pakistan’s pharmaceutical progress.
Driven by our responsibility to healthcare providers and the patients who trust our products, we continuously invest in exceptional talent, adopt cutting-edge technologies, and elevate our standards to meet and exceed global benchmarks. Our processes are guided by sustainability, quality, and continuous improvement.
With over 30% of Pakistan’s population living with diabetes, we are actively developing locally manufactured insulin to reduce dependency on imports and improve accessibility. We are also advancing in biotechnology and vaccine development, building a foundation for future self-reliance in critical therapies.
Our drug development efforts are supported by Pakistan’s largest pharmaceutical R&D lab, a 25,000 sq. ft. facility conducting stability studies and driving product innovation. Furthering our vision, we are developing a Bioequivalence Center—set to open by 2026—to serve as a hub for clinical trials and align Pakistan’s capabilities with international research standards.
We believe collaboration fuels innovation. That’s why Citi Pharma actively pursues and welcomes global partnerships to drive mutual growth, knowledge exchange, and shared impact. By 2050, we aim to expand our global presence, establishing Citi Pharma as a trusted name in international healthcare markets.
In line with our commitment to sustainability, we are proud to target a 90% reduction in carbon emissions by 2030, integrating green practices across our operations to contribute to a healthier planet.
As we move forward, our mission remains clear: to deliver safe, affordable, and innovative healthcare solutions that strengthen both individual well-being and national self-sufficiency.
Route to Success
